Supreme Court hears Roundup cancer warning label case this week

The Supreme Court is set to hear arguments this week regarding a Missouri case where a jury awarded $1.25 million to a man who developed non-Hodgkin lymphoma after using Roundup in a St. Louis community garden. Jurors found Monsanto liable for failing to warn about the cancer risks associated with the herbicide. Bayer, the maker of Roundup, argues that federal pesticide laws preempt state failure-to-warn claims, asserting that states cannot impose additional labeling requirements.

The case has attracted significant attention, with agricultural groups, business associations, health care organizations, plaintiffs' attorneys, and state officials filing around 30 legal briefs urging the court to rule either for or against Bayer's claim of federal legal protection. Notably, the Trump administration has sided with Bayer, reversing the stance of the Biden administration, which may alienate some supporters of the Make America Healthy Again agenda who oppose corporate legal immunity in such matters. A group of former EPA officials has also weighed in, arguing that the absence of a cancer warning on Roundup labels should not preempt state lawsuits, as the company never proposed such a warning to the EPA.

This case underscores the ongoing tension between federal regulatory frameworks and state-level legal actions. Bayer's position could strengthen its legal defenses against similar lawsuits, while the outcome may influence how agricultural chemicals are regulated and labeled in the future. The involvement of former EPA officials adds credibility to the argument for allowing state lawsuits, potentially shifting the balance of power in regulatory oversight.

What to watch: The Supreme Court's decision on this case could set a significant precedent for future liability claims against pesticide manufacturers.